MOXONIDINE: 776 Adverse Event Reports & Safety Profile
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
776
Total FAERS Reports
24 (3.1%)
Deaths Reported
457
Hospitalizations
776
As Primary/Secondary Suspect
46
Life-Threatening
20
Disabilities
First Report: 2000 · Latest Report: 20250501
What Are the Most Common MOXONIDINE Side Effects?
#1 Most Reported
Hypotension
97 reports (12.5%)
#2 Most Reported
Renal impairment
86 reports (11.1%)
#3 Most Reported
Dizziness
85 reports (11.0%)
All MOXONIDINE Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Hypotension | 97 | 12.5% | 0 | 68 |
| Renal impairment | 86 | 11.1% | 1 | 33 |
| Dizziness | 85 | 11.0% | 0 | 65 |
| Hyperkalaemia | 76 | 9.8% | 0 | 27 |
| Abdominal pain | 69 | 8.9% | 0 | 16 |
| Acute kidney injury | 67 | 8.6% | 14 | 53 |
| Bradycardia | 58 | 7.5% | 0 | 36 |
| Drug ineffective | 55 | 7.1% | 1 | 36 |
| Hypertension | 55 | 7.1% | 0 | 46 |
| Nausea | 50 | 6.4% | 0 | 31 |
| Headache | 48 | 6.2% | 0 | 35 |
| Heart failure with preserved ejection fraction | 48 | 6.2% | 0 | 0 |
| Asthenia | 47 | 6.1% | 0 | 27 |
| Fall | 47 | 6.1% | 0 | 46 |
| Fatigue | 44 | 5.7% | 0 | 31 |
| Dyspnoea | 39 | 5.0% | 0 | 23 |
| Serositis | 39 | 5.0% | 0 | 1 |
| Body mass index abnormal | 38 | 4.9% | 0 | 0 |
| Central nervous system lupus | 38 | 4.9% | 0 | 0 |
| Gout | 38 | 4.9% | 0 | 0 |
Who Reports MOXONIDINE Side Effects? Age & Gender Data
Gender: 47.7% female, 52.3% male. Average age: 65.3 years. Most reports from: DE. View detailed demographics →
Is MOXONIDINE Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2000 | 4 | 0 | 0 |
| 2005 | 12 | 0 | 12 |
| 2006 | 3 | 0 | 3 |
| 2008 | 8 | 0 | 8 |
| 2009 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 0 |
| 2011 | 4 | 0 | 4 |
| 2012 | 1 | 0 | 1 |
| 2013 | 12 | 0 | 7 |
| 2014 | 35 | 0 | 20 |
| 2015 | 37 | 0 | 35 |
| 2016 | 12 | 0 | 11 |
| 2017 | 55 | 0 | 46 |
| 2018 | 27 | 1 | 7 |
| 2019 | 48 | 0 | 33 |
| 2020 | 60 | 1 | 17 |
| 2021 | 11 | 0 | 5 |
| 2022 | 29 | 0 | 21 |
| 2023 | 15 | 0 | 14 |
| 2024 | 6 | 0 | 3 |
| 2025 | 4 | 0 | 4 |
What Is MOXONIDINE Used For?
| Indication | Reports |
|---|---|
| Product used for unknown indication | 388 |
| Hypertension | 269 |
| Essential hypertension | 10 |
| Cardiac failure | 8 |
MOXONIDINE vs Alternatives: Which Is Safer?
MOXONIDINE vs MS CONTIN
MOXONIDINE vs MULTAQ
MOXONIDINE vs MULTIHANCE
MOXONIDINE vs MUPIROCIN
MOXONIDINE vs MUPIROCIN\MUPIROCIN
MOXONIDINE vs MUROMONAB-CD3
MOXONIDINE vs MYCOPHENOLATE
MOXONIDINE vs MYCOPHENOLATE MOFETIL
MOXONIDINE vs MYCOPHENOLATE MOFETIL\MYCOPHENOLATE MOFETIL
MOXONIDINE vs MYCOPHENOLIC ACID
Official FDA Label for MOXONIDINE
Official prescribing information from the FDA-approved drug label.